电邮这篇文章 The role of thyroid hypofunction in development of metabolic syndrome
- 作者: Demidova TY.1, Galieva OR1, Demidova TY.1, Galieva OR1
-
隶属关系:
- 期: 卷 81, 编号 4 (2009)
- 页面: 69-72
- 栏目: Editorial
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.04.2009
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30333
- ID: 30333
如何引用文章
全文:
详细
Aim. To study the role of hypothyroidism and concomitant obesity in the development of metabolic syndrome (MS).
Material and methods. We examined 60 women suffering from obesity and hypothyroidism (TTH 22.24 ± 4.031). We studied lipid spectrum, carbohydrate metabolism, BP and insulin resistance, fat tissue distribution, exercise tolerance.
Results. According to IDF (2005) criteria the women had: metabolic syndrome (83.4%), newly diagnosed hypothyroidism (95%), decompensated hypothyroidism (90%), subclinical hypothyroidism (65%) after six-month replacement therapy with L-T4 MS symptoms declined.
Conclusion. Abnormally high level of TSH may be a component of metabolic syndrome.
Material and methods. We examined 60 women suffering from obesity and hypothyroidism (TTH 22.24 ± 4.031). We studied lipid spectrum, carbohydrate metabolism, BP and insulin resistance, fat tissue distribution, exercise tolerance.
Results. According to IDF (2005) criteria the women had: metabolic syndrome (83.4%), newly diagnosed hypothyroidism (95%), decompensated hypothyroidism (90%), subclinical hypothyroidism (65%) after six-month replacement therapy with L-T4 MS symptoms declined.
Conclusion. Abnormally high level of TSH may be a component of metabolic syndrome.
参考
- Biondi B., Palmieri E. A., Lombardi G., Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann. Intern. Med. 2002; 137(11): 904-914.
- Vanderpump M. P., Tunbridge W. M., French J. M. et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996; 6: 155-160.
- Vanderpump M. P., Tunbridge W. M. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002; 12: 839-847.
- Canaris G. J., Manowwitz N. R., Mayor G., Ridgway E. C. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J. of Cen. Intern. Med. 1997; 12: 544-550.
- Diez J. J. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J. Gerontol. 2002; 57(5): 315-320.
- Parle J. V., Franklyn J. A., Cross K. W. et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentration in the elderly in the United Kingdom. Clin. Endocrinol. (Oxford) 1991; 34(1): 77-83.
- Canaris G. J., Manowitz N. R., Mayor G., Ridgway E. C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000: 160: 526-534.
- Мкртумян А. М., Балаболкин М. И., Забелина В. Д. Структура щитовидной железы и состояние тиреоидного обмена при метаболическом синдроме. В кн.: Всероссийская науч.-практ. конф. "Актуальные проблемы заболеваний щитовидной железы: Тезисы докладов. М., 2000. 98-99.
- Hak A. E., Pols H., Visser T. J. et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 2000; 132: 270-278.
补充文件
